Aimmune Therapeutics, Inc. 4
4 · Aimmune Therapeutics, Inc. · Filed Feb 3, 2017
Insider Transaction Report
Form 4
Knapp Jeffrey H
Chief Operating Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2017-02-03$17.89/sh−2,224$39,787→ 2,776 total
Footnotes (1)
- [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.